Drug Profile
Research programme: Alzheimer's disease therapies - Schering Plough/University of Toronto
Alternative Names: Alzheimer's disease therapies research programme - Schering-Plough/University of TorontoLatest Information Update: 07 Jan 2003
Price :
$50
*
At a glance
- Originator Nonindustrial sources
- Developer Nonindustrial sources; Schering-Plough
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 18 Apr 2001 Preclinical development for Alzheimer's disease in Canada (Unknown route)